Botulinum toxin type A Block for the sphenopalatine ganglion in chronic rhinosinusitis With nasal polyposis
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Nasal polyps; Nose disorders; Rhinosinusitis
- Focus Adverse reactions
- 20 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Jun 2018.
- 20 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jun 2018.
- 29 Nov 2016 Status changed from not yet recruiting to recruiting.